Hyperlipidemias: Clinical Trials

28 trials for Hyperlipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 7 recruiting, 3 not yet recruiting, 1 active not recruiting. 28 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 128Completed 14, Recruiting 7, Not yet recruiting 3, Active not recruiting 1, Enrolling by invitation 1, Terminated 1, Unknown 1

Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Team-Based Shared Decision-Making Program in Cardiovascular-Kidney-Metabolic Health (Healthy Heart - CKM)
Team-based shared decision-making - Hypertension (HTN), Diabetes (DM)
Early Phase 1Not yet recruitingJohns Hopkins University942026-10-302026-10-19
CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia
CS-121 - Severe Hypertriglyceridemia (sHTG)
Early Phase 1Not yet recruitingCorrectSequence Therapeutics Co., Ltd152026-06-152026-06-18
CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
CS-121 - Hyperchylomicronemia
Early Phase 1RecruitingShanghai Jiao Tong University School of Medicine152026-01-262026-01-28
CS-121 APOC3 Base Editing in FCS
CS-121 - Familial Chylomicronemia Syndrome (FCS)
Early Phase 1RecruitingCorrectSequence Therapeutics Co., Ltd152025-10-152026-02-11
Truway Diagnostic Tools in Primary Care
Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent - Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Early Phase 1Enrolling by invitationTruway Health, Inc.2002025-10-012026-11-05
The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans
Color Genomics Genetic Testing Panels - Diabetes, Hypercholesterolaemia
Early Phase 1CompletedPennington Biomedical Research Center602025-09-222026-09-24
Differential Thrombogenesis by EPA and DHA Mediated by HDL
EPA, DHA - Lipid Metabolism Disorders, Hypertriglyceridemia
Early Phase 1RecruitingThe Miriam Hospital802025-07-102025-10-01
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Apple Cider Vinegar - Prostate Cancer, Metabolic Syndrome
Early Phase 1RecruitingWestern University302025-07-022025-08-20
Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients
NGGT006 - Refractory Hypercholesterolemia, Familial Hypercholesterolemia
Early Phase 1Not yet recruitingSuzhou Municipal Hospital92024-06-012024-04-17
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
YOLT-101 - Familial Hypercholesterolemia
Early Phase 1RecruitingRenJi Hospital202024-05-242025-04-30
Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
YOLT-101 - Familial Hypercholesterolemia
Early Phase 1UnknownThe First Affiliated Hospital of Bengbu Medical University132024-04-012024-06-17
Time Restricted Eating in Sleep Apnea
Time restricted eating - Time Restricted Eating, Obstructive Sleep Apnea
Early Phase 1RecruitingUniversity of California, San Diego802024-01-052024-01-16
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
NGGT006 - Homozygous Familial Hypercholesterolemia
Early Phase 1RecruitingFirst Affiliated Hospital Xi'an Jiaotong University212023-10-292026-09-03
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
GLY-LOW - Insulin Resistance, Obesity
Early Phase 1CompletedHoskinson Health and Wellness Clinic132023-07-272025-06-10
Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips
Tetrahydrocannabivarin, Placebo - Metabolic Syndrome, Morbid Obesity
Early Phase 1CompletedMedical Life Care Planners, LLC562022-01-042022-10-10
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
Cholesterol metabolism disruption - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer
Early Phase 1Active not recruitingCHU de Quebec-Universite Laval32021-10-042026-03-19
Pediatric Reporting of Adult-Onset Genomic Results
Child(ren) receive an adult-onset result, Child(ren) received a pediatric-onset result, Control - Negative Result - Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome
Early Phase 1CompletedGeisinger Clinic1622020-11-252026-04-09
Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients
Zingiber officinale L. tablets, Simvastatin 20mg - The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients
Early Phase 1CompletedJinnah Sindh Medical University402018-01-012023-01-12
The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia
Rhus Coriaria L. (Rhus), Placebo - Hyperlipidemias
Early Phase 1CompletedShiraz University of Medical Sciences742014-12-012016-06-07
Retinoic Acid Supplementation and Subjects With Hypercholesterolemia
retinoic acid, placebo - Hypercholesterolemia
Early Phase 1CompletedSun Yat-sen University1302014-11-012015-07-15

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Hypercholesterolemia (8)  ·  Obesity (7)  ·  Metabolic Syndrome (6)  ·  Overweight (6)  ·  Hyperlipoproteinemia Type II (5)  ·  Diabetes Mellitus (4)  ·  Hypertension (4)  ·  Hypertriglyceridemia (4)  ·  Cardiovascular Diseases (3)  ·  Hyperglycemia (3)  ·  Pancreatitis (2)  ·  Bone Diseases (1)  ·  Chronic Disease (1)  ·  Cognitive Dysfunction (1)

Broader conditions

Dyslipidemias (28)  ·  Metabolic Diseases (28)  ·  Nutritional and Metabolic Diseases (28)  ·  Lipid Metabolism Disorders (27)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Body Weight (11)  ·  Signs and Symptoms (11)  ·  Nutrition Disorders (10)  ·  Overnutrition (10)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Genetic Diseases, Inborn (9)  ·  Glucose Metabolism Disorders (9)  ·  Metabolism, Inborn Errors (9)  ·  Hyperlipoproteinemias (8)

Interventions

Ezetimibe (2)  ·  Atorvastatin (1)  ·  Chenodeoxycholic Acid (1)  ·  Colchicine (1)  ·  Docosahexaenoic Acids (1)  ·  Eicosapentaenoic Acid (1)  ·  Linseed Oil (1)  ·  Phytosterols (1)  ·  Simvastatin (1)  ·  Tretinoin (1)  ·  evolocumab (1)  ·  ginger extract (1)

Sponsors

CorrectSequence Therapeutics Co., Ltd (2)  ·  University of Jena (2)  ·  Arizona State University (1)  ·  CHU de Quebec-Universite Laval (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Geisinger Clinic (1)  ·  Hoskinson Health and Wellness Clinic (1)  ·  Jinnah Sindh Medical University (1)  ·  Johns Hopkins University (1)  ·  Medical Life Care Planners, LLC (1)  ·  Pennington Biomedical Research Center (1)  ·  RenJi Hospital (1)  ·  Scripps Translational Science Institute (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  Shanghai University of Traditional Chinese Medicine (1)

Countries

United States (9)  ·  China (7)  ·  Canada (2)  ·  Germany (2)  ·  Iran (1)  ·  Mexico (1)  ·  Pakistan (1)  ·  Switzerland (1)

Top investigators

Katrin Kuhnt, Dr. rer. nat (2)  ·  Adam H Buchanan, MS, MPH, CGC (1)  ·  Anne Gangloff, MD PhD FRCPC (1)  ·  Anne-Marie Carreau, MD FRCPC (1)  ·  Arturo Jimenez-Cruz, MD (1)  ·  Cheryl Himmelfarb, PhD (1)  ·  Francine Aubin, MD FRCPC (1)  ·  Guang Ji, MD (1)  ·  Jennifer L. Caldwell, PhD, MPH, MS (1)  ·  Kory Floyd, PhD (1)  ·  Majid Nimruzi, M.D. (1)  ·  Melissa Huynh, MD (1)

Results publications

PMID 26892399, PMID 21768544, PMID 24229084, PMID 24553695, PMID 29397092, PMID 32414353, PMID 41193187, PMID 41776075, PMID 42243546

NIH funding

1UL1TR001114-01 (1), P50MD017338 (1), R01HG009671 (1), R01HL050420 (1), R01HL159204 (1)